Q-Line Biotech IPO

Open Demat Account

Q-Line Biotech IPO Details

Check out the issue details for Q-Line Biotech IPO as disclosed in SEBI.

IPO Price

₹ 343

Price Band

₹ 326 - 343

Issue Size

214.00 Cr.

Issue Type

Book Built

Open

2026-05-21

Close

2026-05-25

Listing price

₹ 452

Listing Gain

31.78%

Listing Date

2026-05-29

CMP

₹ 686.05

Current Return

100.01%

Q-Line Biotech News

Q-Line Biotech coming with IPO to raise up to Rs 214.48 crore20 May 2026, 1:12PM

Company Financials

You can get the following financial statements of Q-Line Biotech as of now.

Company Name

Q-Line Biotech

Exchange

NSE: QLINE

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2025 Mar 2026
Net Sales 313.07 341.16
Total Expenditure 250.73 241.99
Operating Profit 62.34 99.17
Other Income 12.36 5.73
Interest 14.97 18.93
Depreciation 6.93 10.78
Exceptional Items 13.75 -0.98
Profit Before Tax 66.54 74.22
Provision for Tax 19.15 17.27
Net Profit 47.4 56.95
Adjusted EPS (Rs.) 3.01 3.5

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 1.58 16.28
Total Reserves 188.34 231.12
Borrowings 82.41 86.12
Other N/C liabilities 3.09 5.82
Current liabilities 172.39 207.2
Total Liabilities 447.82 546.53
Assets
Net Block 73.37 141.26
Capital WIP 59.03 15.4
Intangible WIP 0 0
Investments 17.96 16.69
Loans & Advances 11.27 10.57
Other N/C Assets 24.44 18.8
Current Assets 261.75 343.81
Total Assets 447.82 546.53
* Other Non-current Liabilities include Net deferred Liabilities

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
May 2026 67.51 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2025 Mar 2026
Profit from operations 66.54 74.22
Adjustment -7.38 29.93
Changes in Assets & Liabilities -28.96 -57.15
Tax Paid -8.4 -26.03
Operating Cash Flow 21.81 20.97
Investing Cash Flow -75.44 -28.94
Financing Cash Flow 46.5 36.35
Net Cash Flow -7.14 28.38
X